Vaxcyte price objective cut to $130 from $133
PCVX•BofA Global Research cut its price objective for Vaxcyte to $130 from $133.
Related News
Alibaba signs multi-year technology and cloud partnership with Brooklyn Nets
BABA•
RideNow Group secures $220 million senior secured term loan from Centerbridge affiliates
RDNW•
Soybeans down 20-24 cents, corn down 4-5 cents, wheat down 6-8 cents
SOYB•
Boeing shares drop; Jefferies flags possible delivery hit from software glitch
BA•
Interlink Electronics to present at Lytham Partners Fall 2026 Investor Conference
LINK•